Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: GlaxoSmithKline
Current Parent Company: GlaxoSmithKline
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $418,952
Year: 2006
Date: August 11, 2006
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Violation Description: GSK agreed to pay $418,951 in settlement of allegations it improperly inflated the average wholesale price paid by government health plans for certain of its prescription drugs. The conduct at issue concerned Glaxo's reporting of pricing data that was used by Medicare and Medicaid to set reimbursement amounts for its drugs Kytril and Zofran, injectible anti-nausea drugs used by patients undergoing chemotherapy.
Level of Government: state
Action Type: agency action
Agency: Georgia Attorney General
Civil or Criminal Case: civil
Facility State: Georgia
HQ Country of Current Parent: United Kingdom
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Notes: Attorney General press release: "The settlement, in conjunction with an earlier Federal Settlement, resulted in $418,951.52 being repaid to Georgia's Medicaid program"
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.